Effect of Position-Based Dosing Strategy for Metaraminol on Neonatal Acid-Base Status During Elective Caesarean Delivery: A Noninferiority Randomised Controlled Trial.
Tianyu Liu, Hua Jiang, Chao Xu, Lei Li, Hong Zhang, Yi Feng
{"title":"Effect of Position-Based Dosing Strategy for Metaraminol on Neonatal Acid-Base Status During Elective Caesarean Delivery: A Noninferiority Randomised Controlled Trial.","authors":"Tianyu Liu, Hua Jiang, Chao Xu, Lei Li, Hong Zhang, Yi Feng","doi":"10.2147/DDDT.S492254","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 15° left tilt position during caesarean delivery has been recommended by guidelines for many years, but recent studies have questioned the clinical benefit of left tilt position. We hypothesize that using a higher starting dose of metaraminol in the supine position will result in a non-inferior umbilical arterial pH, compared to the 15° left tilt position.</p><p><strong>Methods: </strong>Healthy women undergoing elective caesarean delivery were randomized to the supine position (n = 62) or 15° left tilt position (n = 62) after spinal anaesthesia (0.5% bupivacaine 9 mg). Different starting doses of metaraminol infusion were initiated at 2.7 μg kg<sup>-1</sup> min<sup>-1</sup> for the supine position group and 2.0 μg kg<sup>-1</sup> min<sup>-1</sup> for the tilt position group. The infusion rates were then adjusted using a fixed algorithm to maintain systolic blood pressure. The primary outcome was the pH of the umbilical artery.</p><p><strong>Results: </strong>Compared with tilt group, pH (supine group: 7.325 (7.29, 7.35) vs tilt group: 7.33 (7.3, 7.35), P = 0.76) and base excess (tilt group: -0.98 (2.59) mM vs supine group: -0.92 (2.77) mM, P = 0.9) of the umbilical artery are non-inferior. There was no difference in SBP (P = 0.16) or incidence of hypotension (P = 0.75) between the two groups. The incidence of reactive hypertension was greater in the supine position group (P < 0.001).</p><p><strong>Conclusion: </strong>If maternal blood pressure is maintained using the higher starting dose of metaraminol, the left tilted position may not be necessary among healthy patients (BMI less than 35 kg/m<sup>2</sup>) undergoing elective caesarean delivery with spinal anaesthesia.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"18 ","pages":"6209-6219"},"PeriodicalIF":4.7000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668338/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S492254","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The 15° left tilt position during caesarean delivery has been recommended by guidelines for many years, but recent studies have questioned the clinical benefit of left tilt position. We hypothesize that using a higher starting dose of metaraminol in the supine position will result in a non-inferior umbilical arterial pH, compared to the 15° left tilt position.
Methods: Healthy women undergoing elective caesarean delivery were randomized to the supine position (n = 62) or 15° left tilt position (n = 62) after spinal anaesthesia (0.5% bupivacaine 9 mg). Different starting doses of metaraminol infusion were initiated at 2.7 μg kg-1 min-1 for the supine position group and 2.0 μg kg-1 min-1 for the tilt position group. The infusion rates were then adjusted using a fixed algorithm to maintain systolic blood pressure. The primary outcome was the pH of the umbilical artery.
Results: Compared with tilt group, pH (supine group: 7.325 (7.29, 7.35) vs tilt group: 7.33 (7.3, 7.35), P = 0.76) and base excess (tilt group: -0.98 (2.59) mM vs supine group: -0.92 (2.77) mM, P = 0.9) of the umbilical artery are non-inferior. There was no difference in SBP (P = 0.16) or incidence of hypotension (P = 0.75) between the two groups. The incidence of reactive hypertension was greater in the supine position group (P < 0.001).
Conclusion: If maternal blood pressure is maintained using the higher starting dose of metaraminol, the left tilted position may not be necessary among healthy patients (BMI less than 35 kg/m2) undergoing elective caesarean delivery with spinal anaesthesia.
期刊介绍:
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.
The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.
Specific topics covered by the journal include:
Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.